the article doesn't say if stock is up or down, it recently closed at $2.21 a share, could more than double by November if results are good. -----Original Message----- From: Rayilyn Brown Sent: Wednesday, September 19, 2012 10:02 PM To: [log in to unmask] Subject: Pimavanserin stock up want to bet on this? it is the “promising” drug for PD Pyschosis now in Phase III: results are due in November http://www.thestreet.com/story/11703998/1/acadia-pharma-sarepta-therapeutics-how-to-trade-into-trial-results.html?cm_ven=GOOGLEN Ray Rayilyn Brown Past Director AZNPF Arizona Chapter National Parkinson Foundation ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn